This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Fabrinet (FN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Fabrinet (FN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fabrinet (FN) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of 7.14% and 3.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Fabrinet (FN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Fabrinet (FN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 20th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
3 Reasons Why Growth Investors Shouldn't Overlook Fabrinet (FN)
by Zacks Equity Research
Fabrinet (FN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Fabrinet (FN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of 10.34% and 4.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Synopsys (SNPS) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Synopsys' (SNPS) third-quarter fiscal 2020 results likely to reflect benefits from strong demand for its solid product portfolio.
NVIDIA (NVDA) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Though NVIDIA's (NVDA) Q2 performance is likely to have gained from momentum in the data-center business on the pandemic-led work-from-home wave, a fall in global vehicle sales is a concern.
Fabrinet (FN) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Fabrinet (FN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for CACI International's (CACI) Q4 Earnings?
by Zacks Equity Research
CACI International's (CACI) fourth-quarter fiscal 2020 earnings are likely to have gained from organic revenue growth and continued margin expansion.
How Damaging is Coronavirus for Lyft's (LYFT) Q2 Earnings?
by Zacks Equity Research
With coronavirus restricting people to their homes, weakness in ride volumes is expected to have weighed on Lyft's (LYFT) Q2 performance.
10 Power-Packed ETFs to Buy for Second-Half 2020
by Sweta Killa
We have highlighted a pack of ETFs that are poised to outperform in the second half.
Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet
by Zacks Equity Research
Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet
Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio
by Sumit Singh
Interest Coverage Ratio suggests how many times the interest could be paid from earnings and gauges the margin of safety a firm has for paying interest.
Fabrinet (FN) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Fabrinet (FN) delivered earnings and revenue surprises of -1.08% and -0.87%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing Fabrinet (FN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Fabrinet (FN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Fabrinet (FN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FN vs. NJDCY: Which Stock Is the Better Value Option?
by Zacks Equity Research
FN vs. NJDCY: Which Stock Is the Better Value Option?
Add These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
Debt, which is crucial for most of the companies to finance operations, comes at a cost called interest. Interest expense has a direct bearing on the profits of a company.
4 Stocks With Impressive Interest Coverage Ratio to Invest In
by Sumit Singh
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
Should Value Investors Buy Fabrinet (FN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FN vs. TEL: Which Stock Is the Better Value Option?
by Zacks Equity Research
FN vs. TEL: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals
Pick These 4 Stocks With Impressive Interest Coverage Ratio
by Sumit Singh
Debt, which is crucial to financing operations for the majority of companies, comes at a cost called interest. Interest expense has a direct bearing on the profitability of a company.
FN vs. TEL: Which Stock Is the Better Value Option?
by Zacks Equity Research
FN vs. TEL: Which Stock Is the Better Value Option?